Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
Main Authors: | Antepowicz, A, Kirsebom, F, Johansson, C, Gill, D, Hyde, S |
---|---|
Format: | Conference item |
Published: |
Mary Ann Liebert
2018
|
Similar Items
-
Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
by: Antepowicz, A, et al.
Published: (2021) -
Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
by: Agata Antepowicz, et al.
Published: (2021-08-01) -
Effects of palivizumab prophylaxis on respiratory syncytial virus (RSV) infections in Montenegro
by: Envera Lekic, et al.
Published: (2024-05-01) -
Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
by: Harrison C. Bergeron, et al.
Published: (2023-04-01) -
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
by: Asunción Mejías, et al.
Published: (2008-09-01)